1981: Medical: University of Nigeria, Nsukka, Enugu Campus College of Medicine: MD
1981-1982: Internship – University of Nigeria Teaching Hospital, Enugu, Nigeria.
1985-1987: Internal Medicine Residency – University of Nigeria Teaching Hospital, Enugu, Nigeria.
1987-1989: Nephrology Clinical Fellowship – University of Nigeria Teaching Hospital, Enugu, Nigeria.
1994-1996: Nephrology Research Fellowship – University of Texas Health Science Center, Houston, TX.
1996-1997: Nonclinical Nephrology Research Observership – The Johns Hopkins University School of Medicine, Baltimore, MD.
1997-1998: Internship – Greater Baltimore Medical Center, Baltimore, MD.
1998-2000: Internal Medicine Residency - Greater Baltimore Medical Center, Baltimore, MD.
2000-2002: Nephrology Clinical Fellowship – University of Maryland School of Medicine, Baltimore, MD.
2009 -2012: MBA Healthcare Executive – University of Wisconsin Consortium.
Acute kidney injury (AKI) Hypertension
Chronic kidney disease (CKD) Progression
Healthcare Economics
Electronic Medical Records Impact on Physician Work
Medical Bioinformatics and Healthcare Information Technology
TeleMedicine in the developing world
2018-present University of Vermont, Associate Professor of Medicine
2010-2018 Mayo Clinic, Rochester, Associate Professor of Medicine (Retired)
2005-2010 Mayo Clinic, Rochester, Assistant Professor of Medicine
2000-2002 University of Maryland Medical School, Assistant Instructor
1990-1994 University of Nigeria, Senior Lecturer, Medicine
Acute kidney injury (AKI)
Chronic kidney disease (CKD) Progression Intraoperative hypotension in causation of AKI Healthcare Economics
Electronic Medical Records' Impact on Physician Work
End of Life Care and Kidney Disease
Medical Bioinformatics and Healthcare Information Technology
Macaulay Onuigbo, MD MSc MBA FWAP FASN was appointed an Associate Professor of Medicine, in the Division of Nephrology, The Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT on February 12, 2018. He received his MD degree from University of Nigeria, Enugu Campus, Nigeria, Medical School in 1981. He has trained and worked in Nigeria, the United Kingdom and the USA. He has multiple Nephrology Fellowship training experiences in Nigeria, Houston and Baltimore. He retired from Mayo Clinic/Mayo Clinic Health System on January 28, 2018 after more than 15 years of meritorious clinical and academic service.
He has contributed to the modern medical English literature and published and reported on several new syndromes including the syndrome of late onset renal failure from angiotensin blockade (LORFFAB, 2005), the concept of Renoprevention (2009), the syndrome of rapid onset end stage renal disease (SORO-ESRD, 2010), Cognitive Drift with the EMR (2012) and Quadruple Whammy (2013). He has three published Nephrology books, 18 book chapters, over 100 peer-reviewed PubMed cited journal publications, and about 175 published conference abstracts.
He is the Principal Investigator of an industry-sponsored study that involves a Retrospective Chart Review of Patients Using Automated Peritoneal Dialysis With or Without Remote Monitoring here at UVMMC (CHRMS: 18-0490, February 2018 – Present). He is interested in acute kidney injury and in particular, prevention of post-operative acute kidney injury.
He is also working on a new CKD Care Model that involves IT-enabled remote monitoring of kidney function to improve population-wide CKD health. He is a frequent reviewer for journals in Nephrology, Hypertension and General Internal Medicine. He is working on a Telemedicine portal to deliver robust, portable, reliable, convenient, affordable and patient-centered care to patients in the developing world.
1. Onuigbo MA, Onuigbo NT. Late onset renal failure from angiotensin blockade(LORFFAB): a prospective thirty-month Mayo Health System clinic experience. Med Sci Monit 2005 Oct; 11(10):CR462-9. Epub 2005 Sep 26. PMID:16192897.
2. Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: a new unrecognized
pattern of CKD progression to ESRD. Ren Fail. 2010;32(8):954-8.
3. Onuigbo M, Onuigbo N. Aliskiren in Type 2 Diabetes and Cardiorenal End Points. N Engl J Med. 2013 Mar 14;368(11):1064-5. doi: 10.1056/NEJMc1300257#SA1.
(https://www.nejm.org/doi/pdf/10.1056/NEJMc1300257).
4. Onuigbo M, Agbasi N. Association of Intraoperative Hypotension with acute kidney injury after elective non-cardiac surgery – prevention is better than cure. Ren Fail 2016, 38(1):168-9.
5. Rafique Z, Weir MR, Onuigbo M, Pitt B, Lafayette R, Butler J, Lopes M, Farnum C, Peacock WF. Expert Panel Recommendations for the Identification and Management of
Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart
Failure. J Manag Care Spec Pharm. 2017 Apr;23(4-a Suppl):S10-S19. doi: 10.18553/jmcp.2017.23.4-a.s10.